Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis

Hoyo, Javier del; Nos, Pilar; Bastida, Guillermo; Faubel, Raquel; Muñoz, Diana; Garrido-Marín, Alejandro; Valero-Pérez, Elena; Béjar-Serrano, Sergio; Aguas, Mariam

doi:10.2196/15505

Cited by 32 publications

(24 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is not known whether the lack of close monitoring due to social distancing measures can lead, in the short- or long-term, to higher rates of clinical relapse or loss of response to therapy. In general, there is a need to restructure the IBD unit, use telemonitoring [ 34 , 35 ], or send questionnaires to the patients through emails, mobile communication applications, and text messaging to monitor their progress and detect adverse events that could be missed in those who are not under closer monitoring [ 36 ]. This is an important consideration during the COVID-19 outbreak: namely, to detect patients who need immediate medical attention and those who may postpone their appointments.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil

Feitosa¹,

Parra²,

Camargo³

et al. 2020

aog

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil

Feitosa¹,

Parra²,

Camargo³

et al. 2020

aog

View full text Add to dashboard Cite

“…One randomized controlled study conducted by de Jong et al [ 29 ] compared the cost-effectiveness of telemedicine and standard care for management of IBD; they found that telemedicine was safe and reduced outpatient visits and hospital admissions compared with standard care. Del Hoyo et al [ 30 ] suggested that compared with standard and telephone care, telemedicine with web-based programs decreased the direct and indirect costs for patients with IBD; other studies by Elkjaer [ 31 ] and de Jong [ 32 ] have shown similar results. Mao et al [ 33 ] mentioned that CCCF has organized a group of volunteer gastroenterologists that specialize in IBD to offer web-based consultancy to patients with IBD.…”

Section: Discussionmentioning

confidence: 94%

Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study

Zhu

Shi

et al. 2021

J Med Internet Res

View full text Add to dashboard Cite

Background The increasing incidence of inflammatory bowel disease (IBD) has imposed heavy financial burdens for Chinese patients; however, data about their financial status and access to health care are still lacking. This information is important for informing patients with IBD about disease treatment budgets and health care strategies. Objective The aim of this study was to evaluate the economic status and medical care access of patients with IBD through the China Crohn’s & Colitis Foundation web-based platform in China. Methods Our study was performed in 14 IBD centers in mainland China between 2018 and 2019 through WeChat. Participants were asked to complete a 64-item web-based questionnaire. Data were collected by the Wenjuanxing survey program. We mainly focused on income and insurance status, medical costs, and access to health care providers. Respondents were stratified by income and the associations of income with medical costs and emergency visit times were analyzed. Results In this study, 3000 patients with IBD, that is, 1922 patients with Crohn disease, 973 patients with ulcerative colitis, and 105 patients with undetermined colitis were included. During the last 12 months, the mean (SD) direct and indirect costs for per patient with IBD were approximately US $11,668.68 ($7944.44) and US $74.90 ($253.60) in China. The average reimbursement ratios for most outpatient and inpatient costs were less than 50%. However, the income of 85.5% (2565/3000) of the patients was less than ¥10,000 (US $1445) per month. Approximately 96.5% (2894/3000) of the patients were covered by health insurance, but only 24.7% (741/3000) of the patients had private commercial insurance, which has higher imbursement ratios. Nearly 98.0% (2954/3000) of the patients worried about their financial situation. Thus, 79.7% (2392/3000) of the patients with IBD tried to save money for health care and even delayed their medical treatments. About half of the respondents (1282/3000, 42.7%) had no primary care provider, and 52.2% (1567/3000) of the patients had to visit the emergency room 1-4 times per year for the treatment of their IBD. Multivariate analysis revealed that lower income ( P =.001) and higher transportation ( P =.004) and accommodation costs ( P =.001) were significantly associated with the increased number of emergency visits of the patients. Conclusions Chinese patients with IBD have enormous financial burdens and difficulties in accessing health care, which have increased their financial anxiety and inevitably influenced their disease outcomes. Early purchase of private insurance, thereby increasing the reimbursement ratio for medical expenses, and developing the use of telemedicine would be effective strategies for saving on health care costs.

show abstract

“…In the field of gastroenterology, there are numerous application scenarios for telemedical care concepts, such as general digestive disease management programs[ 53 ]. Other telemedical tools are offered for IBD[ 54 , 55 ], CLDs[ 6 ], liver transplant patients[ 56 ] or diabetes patients[ 57 ]. In a literature review from Serper et al[ 6 ], the authors illustrated different uses for telemedicine in CLDs.…”

Section: Opportunitiesmentioning

confidence: 99%

Impact of mobile health and medical applications on clinical practice in gastroenterology

Kernebeck¹,

Busse²,

Böttcher³

et al. 2020

WJG

View full text Add to dashboard Cite

Mobile health apps (MHAs) and medical apps (MAs) are becoming increasingly popular as digital interventions in a wide range of health-related applications in almost all sectors of healthcare. The surge in demand for digital medical solutions has been accelerated by the need for new diagnostic and therapeutic methods in the current coronavirus disease 2019 pandemic. This also applies to clinical practice in gastroenterology, which has, in many respects, undergone a recent digital transformation with numerous consequences that will impact patients and health care professionals in the near future. MHAs and MAs are considered to have great potential, especially for chronic diseases, as they can support the self-management of patients in many ways. Despite the great potential associated with the application of MHAs and MAs in gastroenterology and health care in general, there are numerous challenges to be met in the future, including both the ethical and legal aspects of applying this technology. The aim of this article is to provide an overview of the current status of MHA and MA use in the field of gastroenterology, describe the future perspectives in this field and point out some of the challenges that need to be addressed.

show abstract

Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis

Cited by 32 publications

References 44 publications

COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil

COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil

Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study

Impact of mobile health and medical applications on clinical practice in gastroenterology

Contact Info

Product

Resources

About